Cover Image

A RARE CASE OF TYROSINEMIA TYPE I

SENTHILNESH A

Abstract


Tyrosinemia type1 is a rare autosomal recessive metabolic disorder, characterized by the lack of enzyme   fumaryl acetoacetate hydrolase which is involved in  metabolism of aminoacid tyrosine. This lead to abnormal accumulation of tyrosine and its metabolites in the liver, leading to liver disease. Tyrosinemia has rarely been reported in india due to lack of diagnostic facilities. We present a case of tyrosinemia type1 confirmed with plasma and urinary succinylacetone.

 


Full Text:

PDF

References


Nelson Textbook of paediatrics. First southasia edition. Volume-1 .Kliegman. Stanton.St Geme. Schor. chapter 85.Defects in metabolism of aminoacids.page number640.

Essential paediatrics. seventh edition.Op Ghai.Vinod K

Paul.Arvind Bagga.chapter 22.Inborn errors of metabolism.page number629.

Mitchell GA, Grompe M, Lambert M, et al. Hypertyrosinemia. In: Scriver CR, Beaudet AL, Sly W, Valle D, eds. The Metabolic and Molecular Basis of Inherited Disease, 9th ed. New York: McGraw-Hill, 2001:1777–1805

Levine SZ, Marples E, Gordon HH. A defect in the metabolism of aromatic amino acids in premature infants: The role of vitamin C. Science 1939;90:620

Kvittingen E. Hereditary tyrosinemia type I—an overview. Scand J Clin Lab Invest 1986;46:27–34 .

Mitchell G, Larochelle J, Lambert M, et al. Neurologic crises in hereditary tyrosinemia. N Engl J Med 1990;322:432–437

Croffie JM, Gupta SK, Chong SK, et al. Tyrosinemia type 1 should be suspected in infants with severe coagulopathy even in the absence of other signs of liver failure. Pediatrics 1999; 103:675–678

De Braekeleer M, Larochelle J. Genetic epidemiology of hereditary tyrosinemia in Quebec and in Saguenay-Lac -St-Jean. Am J Hum Genet 1990;47:302–307

Labelle Y, Phaneuf D, Leclerc B, et al. Characterization of the human fumarylacetoacetate hydrolase gene and identification of a missense mutation abolishing enzymatic activity. Hum Mol Genet 1993;2:941–946

St-Louis M, Leclerc B, Laine J, et al. Identification of a stop mutation in five Finnish patients suffering from hereditary tyrosinemia type I. Hum Mol Genet 1994;3:69–72

Grompe M, St-Louis M, Demers SI, et al. A single mutation of the fumarylacetoacetate hydrolase gene in French Canadians with hereditary tyrosinemia type I. N Engl J Med 1994; 331:353–357

Jakobs C, Stellaard F, Kvittingen EA, et al. First-trimester prenatal diagnosis of tyrosinemia type I by amniotic fluid succinylacetone determination. Prenat Diagn 1990;10:133–134

Grenier A, Cederbaum S, Laberge C, et al. A case of tyrosinaemia type I with normal level of succinylacetone in the amniotic fluid. Prenat Diagn 1996;16:239–242

Kvittingen EA, Steinmann B, Gitzelmann R, et al. Prenatal diagnosis of hereditary tyrosinemia by determination of fumarylacetoacetase in cultured amniotic fluid cells. Pediatr Res 1985;19:334–337

Demers SI, Phaneuf D, Tanguay RM. Hereditary tyrosinemia type I: strong association with haplotype 6 in French Canadians permits simple carrier detection and prenatal diagnosis. Am J Hum Genet 1994;55:327–333


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An Initiative of The Tamil Nadu Dr MGR Medical University